🇸🇳 Senegal Prävalenz von Weiblicher Genitalverstümmelung
Senegal Prävalenz von Weiblicher Genitalverstümmelung was 20.10 in 2023, down 20.2% from 2019, according to World Bank data. The 10-year average is 24.23. Historical data available from 2005 to 2023 (9 data points). The all-time high was 28.20 in 2005.
Source: World Bank World Development Indicators • 2005–2023 • 9 data points • Health
Latest Value
20.10
2023
Year-on-Year
-20.2%
vs 2019
10-Year Average
24.23
2014–2023
Range
High: 28.20 (2005)
Low: 20.10 (2023)
Senegal Prävalenz von Weiblicher Genitalverstümmelung (%) — 2005 to 2023
Loading chart...
About this Indicator
Percentage of women aged 15–49 who have gone through partial or total removal of the female external genitalia or other injury to the female genital organs for cultural or other non-therapeutic reasons.
Historical Data Table
| Year | Value |
|---|---|
| 2023 | 20.10 |
| 2019 | 25.20 |
| 2018 | 23.30 |
| 2017 | 24.00 |
| 2016 | 22.70 |
| 2015 | 24.20 |
| 2014 | 24.70 |
| 2011 | 25.70 |
| 2005 | 28.20 |
Embed this chart
Copy and paste this code to embed the chart on your website:
<iframe src="https://nationstat.com/de/country/senegal/female-genital-mutilation-prevalence" width="800" height="500" frameborder="0"></iframe>Compare with Other Countries
🇧🇯Benin
9.202014
🇧🇫Burkina Faso
56.102021
🇨🇫Zentralafrikanische Republik
21.602019
🇨🇮Elfenbeinküste
36.702016
🇨🇲Kamerun
1.402004
🇩🇯Dschibuti
90.102019
🇪🇬Ägypten
87.202015
🇪🇷Eritrea
83.002010
🇪🇹Äthiopien
65.202016
🇬🇭Ghana
2.402018
🇬🇳Guinea
94.502018
🇬🇲Gambia
72.602020
🇬🇼Guinea-Bissau
52.102019
🇮🇶Irak
7.402018
🇰🇪Kenia
14.802022
🇱🇷Liberia
31.802020
🇲🇻Malediven
12.902017
🇲🇱Mali
88.602018
🇲🇷Mauretanien
63.902021
🇳🇪Niger
2.002012
🇳🇬Nigeria
15.102021
🇸🇩Sudan
86.602014
🇸🇳Senegal
20.102023
🇸🇱Sierra Leone
83.002019
🇸🇴Somalia
99.202020
🇹🇩Tschad
34.102019
🇹🇬Togo
3.102017
🇹🇿Tansania
8.202022
🇺🇬Uganda
0.302016
🇾🇪Jemen
18.502013
Related Indicators
Erwachsene (15+ Jahre) und Kinder (0-14 Jahre) kürzlich mit HIV infiziert
3.0K
2024
Erwachsene (15-49 Jahre) kürzlich mit HIV infiziert
2.6K
2024
Abdeckung antiretroviraler Therapie für PMTCT (% schwangere mit HIV)
94.0
2024
Abdeckung der antiretroviralen Therapie (% HIV-positive Personen)
79.0
2024
Demografischer Abhängigenquotient (% der erwerbstätigen Bevölkerung)
71.8
2024